Comprehensive meta-analysis and meta-regression of peripartum cardiomyopathy: risk factors, cardiac function, and maternal-neonatal outcomes in 66,908 PPCM patients
Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: BACKGROUND: Peripartum cardiomyopathy (PPCM) is a potentially life-threatening condition and often diagnosed late, with many patients presenting in advanced heart failure. This study aimed to examine the demographics, risk factors, comorbidities, clinical characteristics, treatment patterns, and maternal and neonatal outcomes METHODS AND RESULTS: This meta-analysis followed PRISMA guidelines. A total of 4,341 records up to May 2025, were identified and 122 eligible studies reporting PPCM clinical characteristics, treatments, and outcomes were included. Heterogeneity was explored through meta-regression analyses assessing demographic, clinical, and study-level variables. An aggregate of 66,908 PPCM patients were reported across the included studies, with a pooled mean age of 30.1 years. Black or African women accounted for a disproportionately large proportion of the reported population compared with other racial groups. Approximately 62% of women presented with advanced heart failure (NYHA class III/IV). Pre-existing diabetes mellitus (OR 5.09) and hypertensive disorders, including pre-existing hypertension (OR 10.07), gestational hypertension (OR 7.75), and pre-eclampsia (OR 9.27), were associated with higher odds of PPCM. The pooled mean LVEF at diagnosis was 29.98%, which subsequently improved to 46.47% at 6 months and 49.12% at 12 months. Despite over half of PPCM patients achieving LVEF recovery (55%), maternal mortality remained high at 6% and neonatal mortality at 4%. Pharmacological treatments for PPCM varied widely, with high heterogeneity suggesting substantial differences in prescribing practices across studies. CONCLUSION: The high prevalence of NYHA class III/IV symptoms at diagnosis underscores the importance of early detection and monitoring, while the variation in reported use of guideline-directed medical therapy (GDMT) across studies highlights potential opportunities to optimize treatment in patients with PPCM. The observed improvement in LVEF during follow-up indicates that cardiac recovery is possible in patients with PPCM. However, these findings should be interpreted cautiously given the observational nature and substantial heterogeneity of the included studies.
Source: The Egyptian Heart Journal
Authors: Kellyn Trycia Zenjaya(Conceptualization, Methodology), Christopher Christopher, Reinard Arthur Timothy, Cindy Clareta Thiehunan, Sang Ayu Putu Wulan Sukmawati, Kelvin Pintono, Jovan Amadeo Muliyanto, Evan Ricardo, Annisa Salsabilla Dwi Nugrahani(Writing – review & editing), Julian Hoevelmann
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7234546593
